Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral hyoscine for outpatient cervical ripening in nulliparous term pregnant women
PACTR202605759587564Not yet recruiting
- Sponsor
- ADENUGA TAIWO OLAMILEKAN
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cervical ripening (CR) comparing Oral hyoscine N-butylbromide with Placebo (2 arms). Primary endpoints: Bishop score at hospital admission or labor onset and Favorable cervix achievement. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on PACTR202605759587564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605759587564.